Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue
- 11 November 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (46) , 21157-21173
Abstract
The mechanism of action (MoA) of a clickable fatty acid analogue 8-(2-cyclobuten-1-yl)octanoic acid (DA-CB) has been investigated for the first time. Proteomics, metabolomics, and lipidomics were combined with a network analysis to investigate the MoA of DA-CB against Mycobacterium smegmatis (Msm). The metabolomics results showed that DA-CB has a general MoA related to that of ethionamide (ETH), a mycolic acid inhibitor that targets enoyl-ACP reductase (InhA), but DA-CB likely inhibits a step downstream from InhA. Our combined multi-omics approach showed that DA-CB appears to disrupt the pathway leading to the biosynthesis of mycolic acids, an essential mycobacterial fatty acid for both Msm and Mycobacterium tuberculosis (Mtb). DA-CB decreased keto-meromycolic acid biosynthesis. This intermediate is essential in the formation of mature mycolic acid, which is a key component of the mycobacterial cell wall in a process that is catalyzed by the essential polyketide synthase Pks13 and the associated ligase FadD32. The multi-omics analysis revealed further collateral alterations in bacterial metabolism, including the overproduction of shorter carbon chain hydroxy fatty acids and branched chain fatty acids, alterations in pyrimidine metabolism, and a predominate downregulation of proteins involved in fatty acid biosynthesis. Overall, the results with DA-CB suggest the exploration of this and related compounds as a new class of tuberculosis (TB) therapeutics. Furthermore, the clickable nature of DA-CB may be leveraged to trace the cellular fate of the modified fatty acid or any derived metabolite or biosynthetic intermediate.Keywords
Funding Information
- National Center for Research Resources (RR015468-01)
- National Institute of Food and Agriculture (NEB-39-178, NEB-39-179)
- National Institute of General Medical Sciences (P20 GM113126, P30 GM103335)
This publication has 78 references indexed in Scilit:
- Metabolomics and Proteomics Annotate Therapeutic Properties of Geniposide: Targeting and Regulating Multiple Perturbed PathwaysPLOS ONE, 2013
- Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro DormancyPLOS ONE, 2012
- Mapping intact protein isoforms in discovery mode using top-down proteomicsNature, 2011
- Predicting the in Vivo Mechanism of Action for Drug Leads Using NMR MetabolomicsACS Chemical Biology, 2011
- Mycobacterium tuberculosisacyl carrier protein synthase adopts two different pH-dependent structural conformationsActa Crystallographica Section D Structural Biology, 2011
- New drugs and regimens for treatment of TBExpert Review of Anti-infective Therapy, 2010
- Cell wall proteome analysis of Mycobacterium smegmatis strain MC2 155BMC Microbiology, 2010
- The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosisJournal of Biological Chemistry, 2009
- Use of NMR Metabolomics To Analyze the Targets of d-Cycloserine in Mycobacteria: Role of d-Alanine RacemaseJournal of Proteome Research, 2007
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007